Article

Activities in Brazil focus on risk factors, glaucoma prevention

Brazil has organized a number of activities for the first World Glaucoma Day.

Juiz de Fora, Minas Gerais, Brazil-The Centro Oftalmológico Paletta Guedes here organized a number of activities for the first World Glaucoma Day (WGD). Located in a region of more than 2 million people, the center is one of few in the area with a specialized glaucoma department and has organized two major regional campaigns directed to the general population in previous years.

"Our key message is the importance of a regular preventive visit to the eye-care specialist and to enhance awareness in the population about the main risk factors for glaucoma," said Dr. Ricardo Paletta Guedes.

WGD activities included:

  • Free open-clinic day exams were given to first-degree relatives of patients with glaucoma. Eye exams including tonometry, pachymetry, gonioscopy, funduscopy, and Humphrey visual fields were performed at the center. Current guidelines for glaucoma screening and targeting high-risk patients (first-degree relatives aged 40 years and older) were followed.

  • In conjunction with the local branch of the Brazilian Association of Glaucoma Patients, lectures about risk factors and glaucoma prevention were presented three times during the day by glaucoma specialists Dr. Ricardo and Dr. Vanessa Paletta Guedes. The association also provided ancillary personnel for the open-clinic day.

  • Local TV, radio, and newspaper outlets were contacted to disseminate information about glaucoma.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.